BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 28779853)

  • 1. Preliminary psychometric properties of the brief Negative Symptom Scale in youth at Clinical High-Risk for psychosis.
    Strauss GP; Chapman HC
    Schizophr Res; 2018 Mar; 193():435-437. PubMed ID: 28779853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial development and preliminary psychometric properties of the Prodromal Inventory of Negative Symptoms (PINS).
    Pelletier-Baldelli A; Strauss GP; Visser KH; Mittal VA
    Schizophr Res; 2017 Nov; 189():43-49. PubMed ID: 28189529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric Properties of Prodromal Questionnaire-Brief Version among Chinese Help-Seeking Individuals.
    Xu L; Zhang T; Zheng L; Li H; Tang Y; Luo X; Sheng J; Wang J
    PLoS One; 2016; 11(2):e0148935. PubMed ID: 26859774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Italian version of the 92-item Prodromal Questionnaire: Concurrent validity with the SIPS and factor analysis in a sample of 258 outpatients aged 11-36years.
    Kotzalidis GD; Solfanelli A; Piacentino D; Savoja V; Fiori Nastro P; Curto M; Lindau JF; Masillo A; Brandizzi M; Fagioli F; Raballo A; Gebhardt E; Preti A; D'Alema M; Fucci MR; Miletto R; Andropoli D; Leccisi D; Girardi P; Loewy RL; Schultze-Lutter F
    Schizophr Res; 2017 Nov; 189():50-56. PubMed ID: 28254200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying youth at risk for psychosis using the Behavior Assessment System for Children, Second Edition.
    Thompson E; Kline E; Reeves G; Pitts SC; Schiffman J
    Schizophr Res; 2013 Dec; 151(1-3):238-44. PubMed ID: 24119463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosis-like experiences and distress among adolescents using mental health services.
    Kline E; Thompson E; Bussell K; Pitts SC; Reeves G; Schiffman J
    Schizophr Res; 2014 Feb; 152(2-3):498-502. PubMed ID: 24411529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting psychosis in a general adolescent psychiatric sample.
    Lindgren M; Manninen M; Kalska H; Mustonen U; Laajasalo T; Moilanen K; Huttunen M; Cannon TD; Suvisaari J; Therman S
    Schizophr Res; 2014 Sep; 158(1-3):1-6. PubMed ID: 25015028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prodromal psychosis detection in a counseling center population in China: an epidemiological and clinical study.
    Zhang T; Li H; Woodberry KA; Seidman LJ; Zheng L; Li H; Zhao S; Tang Y; Guo Q; Lu X; Zhuo K; Qian Z; Chow A; Li C; Jiang K; Xiao Z; Wang J
    Schizophr Res; 2014 Feb; 152(2-3):391-9. PubMed ID: 24387999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The brief negative symptom scale: validation of the German translation and convergent validity with self-rated anhedonia and observer-rated apathy.
    Bischof M; Obermann C; Hartmann MN; Hager OM; Kirschner M; Kluge A; Strauss GP; Kaiser S
    BMC Psychiatry; 2016 Nov; 16(1):415. PubMed ID: 27876020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emotional and behavioral symptomatology reported by help-seeking youth at clinical high-risk for psychosis.
    Thompson E; Kline E; Ellman LM; Mittal V; Reeves GM; Schiffman J
    Schizophr Res; 2015 Mar; 162(1-3):79-85. PubMed ID: 25638728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Psychometric Comparison of the Clinical Assessment Interview for Negative Symptoms and the Brief Negative Symptom Scale.
    Strauss GP; Gold JM
    Schizophr Bull; 2016 Nov; 42(6):1384-1394. PubMed ID: 27174556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms.
    Addington J; Liu L; Buchy L; Cadenhead KS; Cannon TD; Cornblatt BA; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; McGlashan TH
    J Nerv Ment Dis; 2015 May; 203(5):328-35. PubMed ID: 25919383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and prediction of clinical high risk of psychosis in Chinese outpatients using two-stage screening.
    Xu L; Wang Y; Cui H; Tang Y; Wang J; Tang X; Zhang B; Wei Y; Zhu Y; Jiang L; Qian Z; Li H; Zhang T; Wang J
    Schizophr Res; 2018 Dec; 202():284-290. PubMed ID: 29929774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Course of psychotic symptoms, depression and global functioning in persons at clinical high risk of psychosis: Results of a longitudinal observation study over three years focusing on both converters and non-converters.
    Hengartner MP; Heekeren K; Dvorsky D; Walitza S; Rössler W; Theodoridou A
    Schizophr Res; 2017 Nov; 189():19-26. PubMed ID: 28139360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptom assessment in early psychosis: the use of well-established rating scales in clinical high-risk and recent-onset populations.
    Fulford D; Pearson R; Stuart BK; Fisher M; Mathalon DH; Vinogradov S; Loewy RL
    Psychiatry Res; 2014 Dec; 220(3):1077-83. PubMed ID: 25278477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The WERCAP Screen and the WERC Stress Screen: psychometrics of self-rated instruments for assessing bipolar and psychotic disorder risk and perceived stress burden.
    Mamah D; Owoso A; Sheffield JM; Bayer C
    Compr Psychiatry; 2014 Oct; 55(7):1757-71. PubMed ID: 25128205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor analysis of the Scale of Prodromal Symptoms: data from the Early Detection and Intervention for the Prevention of Psychosis Program.
    Tso IF; Taylor SF; Grove TB; Niendam T; Adelsheim S; Auther A; Cornblatt B; Carter CS; Calkins R; Ragland JD; Sale T; McFarlane WR
    Early Interv Psychiatry; 2017 Feb; 11(1):14-22. PubMed ID: 25529847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Early Psychosis Screener (EPS): Quantitative validation against the SIPS using machine learning.
    Brodey BB; Girgis RR; Favorov OV; Addington J; Perkins DO; Bearden CE; Woods SW; Walker EF; Cornblatt BA; Brucato G; Walsh B; Elkin KA; Brodey IS
    Schizophr Res; 2018 Jul; 197():516-521. PubMed ID: 29358019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability and validity of the Calgary Depression Scale for Schizophrenia (CDSS) in youth at clinical high risk for psychosis.
    Addington J; Shah H; Liu L; Addington D
    Schizophr Res; 2014 Mar; 153(1-3):64-7. PubMed ID: 24439270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosis risk screening in youth: a validation study of three self-report measures of attenuated psychosis symptoms.
    Kline E; Wilson C; Ereshefsky S; Denenny D; Thompson E; Pitts SC; Bussell K; Reeves G; Schiffman J
    Schizophr Res; 2012 Oct; 141(1):72-7. PubMed ID: 22921375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.